1Olek A, Oswald J, Walte J. A modified and improved method for bisulphate based cytasine methylation analysis. Nucleic Acids Research, 1996,24:5064-5066.
2Shen DH,Chan KYK,Khoo US,et al. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Carcinogenesis ,2005,26:855- 863.
4Coopman PJP, Do MTH, Barth M, et al, The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature, 2000,406: 742-747.
5Yuan YF, Mendez R., Sahin A , et al. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 2001, 61:5558-5561.
6Herman JG , Graff JR , Myohanen S , et al. Methylation-speeifie PCR, a novel PCR assay for methylation status of CPG islands. Proc Natl Acad Sci USA 1996, 93 : 9821-9826.
7Kiyonao S, Tomoko T, Shigeru Y, et al. Structure and Function of Syk Protein-Tyrosine Kinase. J Biochem, 2001, 130,177-186.
8Murphy M, Schnall R, Venter D, et al. Tissue hyperplasia and enhanced T-cell signaling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol ,1998, 18. 4872-4882.
9Okamura S, NR CC, Koyama k, et al. Identification of seven genes regulated by wild-type p53 in a colon cancer cell carrying a well-controiled wild-type p53 expression system. Oncol Res, 1999, 11:281-285.
10Garkavtsev I, Grigorian IA, Ossovskaya VS,et al. The candidate tumor suppressor P33ING1 cooperates with p53 in cell growth control. Nature, 1998, 391:295-298.
